Clinical trial
Gemcitabine, Infusional 5 Fluorouracil and Bevacizumab in Patients With Advanced…
NCT00417976 · Tony Bekaii-Saab, Other · Completed
Key facts
| NCT number | NCT00417976 |
|---|---|
| Title | Gemcitabine, Infusional 5 Fluorouracil and Bevacizumab in Patients With Advanced Pancreas Cancer |
| Official title | A Phase II Study of the Combination of Fixed Dose Rate Gemcitabine, Infusional 5 Fluorouracil and Bevacizumab in Patients With Advanced Pancreas Cancer |
| Lead sponsor | Tony Bekaii-Saab, Other |
| Collaborators | Genentech, Inc. Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pancreatic Cancer |
| Intervention type | Drug |
| Interventions | Gemcitabine, Bevacizumab, Infusional 5-Fluorouracil |
| Enrollment | 42 |
| Start date | Dec 1, 2006 |
| Primary completion | Mar 1, 2010 |
| Completion | Feb 1, 2011 |
| First posted | Jan 4, 2007 |
| Last update posted | Oct 1, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: